Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D)

Project description

Innovative treatment for autoimmune diabetes

Fields of science

• social sciences › economics and business › business and management › entrepreneurship
• medical and health sciences › clinical medicine › endocrinology › diabetes
• medical and health sciences › basic medicine › immunology › autoimmune diseases
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

AHEAD THERAPEUTICS SL

Net EU contribution

€ 50 000,00

Address

Edifici Eureka Parc Recerca Uab Campus Uab S/n
08193 Cerdanyola Del Valles
Spain

Region

Este › Cataluña › Barcelona

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00